文献リスト

1) Nevin S. Glimatosis cerebri. Brain. 1938; 61: 170-91

2) Zulch KJ. Histological Typing of Tumours of the Central Nervous System (International Histological Classification of Tumours, No. 21). World Health Organization, Geneva. 1979

3) Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. Berlin: Springer-Verlag; 1993

4) Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press; 2000

5) Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification of Tumours of the Central nervous System. Lyon: IARC; 2007

6) Pyhtinen J, Paakko E. A difficult diagnosis of gliomatosis cerebri. Neuroradiology. 1996; 38: 444-8

7) Akimoto J, Nishioka H, Miki T, et al. Clinical diagnosis of gliomatosis cerebri: report of three cases. Brain Tumor Pathol. 2004; 21: 87-95

8) del Carpio-O'Donovan R, Korah I, Salazar A, et al. Gliomatosis cerebri. Radiology. 1996; 198: 831-5

9) Shin YM, Chang KH, Han MH, et al. Gliomatosis cerebri: comparison of MR and CT features. AJR Am J Roentgenol. 1993; 161: 859-62

10) Yu A, Li K, Li H. Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri. Eur J Radiol. 2006; 59: 216-21

11) Vates GE, Chang S, Lamborn KR, et al. Gliomatosis cerebri: a review of 22 cases. Neurosurgery. 2003; 53: 261-71

12) Uchino A, Takase Y, Nomiyama K, et al. Acquired lesions of the corpus callosum: MR imaging. Eur Radiol. 2006; 16: 905-14

13) Bendszus M, Warmuth-Metz M, Klein R, et al. MR spectroscopy in gliomatosis cerebri. AJNR Am J Neuroradiol. 2000; 21: 375-80

14) Chen CY, Lirng JF, Chan WP, et al. Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors. J Formos Med Assoc. 2004; 103: 448-58

15) Kararizou E, Likomanos D, Gkiatas K, et al. Magnetic resonance spectroscopy: a noninvasive diagnosis of gliomatosis cerebri. Magn Reson Imaging. 2006; 24: 205-7

16) Yaguchi M, Nakasone A, Sohmiya M, et al. Gliomatosis cerebri involving the lumbosacral spinal cord. Intern Med. 2003; 42: 615-8

17) Galanaud D, Chinot O, Nicoli F, et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg. 2003; 98: 269-76

18) Saraf-Lavi E, Bowen BC, Pattany PM, et al. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels. AJNR Am J Neuroradiol. 2003; 24: 946-51

19) Mohana-Borges AV, Imbesi SG, Dietrich R, et al. Role of proton magnetic resonance spectroscopy in the diagnosis of gliomatosis cerebri: a unique pattern of normal choline but elevated Myo-inositol metabolite levels. J Comput Assist Tomogr. 2004; 28: 103-5

20) Uysal E, Erturk M, Yildirim H, et al. Multivoxel magnetic resonance spectroscopy in gliomatosis cerebri. Acta Radiol. 2005; 46: 621-4

21) Guzman-de-Villoria JA, Sanchez-Gonzalez J, Munoz L, et al. 1H MR spectroscopy in the assessment of gliomatosis cerebri. AJR Am J Roentgenol. 2007; 188: 710-4

22) Sato N, Inoue T, Tomiyoshi K, et al. Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography. Neuroradiology. 2003; 45: 700-7

23) Maramattom BV, Giannini C, Manno EM, et al. Gliomatosis cerebri angiographically mimicking central nervous system angiitis: case report. Neurosurgery. 2006; 58: E1209

24) Beppu T, Inoue T, Shibata Y, et al. Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neurooncol. 2003; 63: 109-16

25) Inoue T, Ogasawara K, Beppu T, et al. Three-dimensional anisotropy contrast imaging of gliomatosis cerebri: two case reports. Surg Neurol. 2004; 62: 151-4

26) Akai H, Mori H, Aoki S, et al. Diffusion tensor tractography of gliomatosis cerebri: fiber tracking through the tumor. J Comput Assist Tomogr. 2005; 29: 127-9

27) 青木 茂, 増谷佳孝, 阿部 修. 神経疾患と拡散tractography─その応用と限界. Brain and Nerve. 2007; 59: 467-76

28) Levin N, Gomori JM, Siegal T. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology. 2004; 63: 354-6

29) Lodi R, Setola E, Tonon C, et al. Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration. Magn Reson Imaging. 2003; 21: 1003-7

30) Hargrave D, Bouffet E, Gammon J, et al. Response to low dose temozolomide in radiation induced gliomatosis cerebri. Med Pediatr Oncol. 2003; 41: 562-4

31) Sanson M, Cartalat-Carel S, Taillibert S, et al. Initial chemotherapy in gliomatosis cerebri. Neurology. 2004; 63: 270-5

32) Louis E, Keime-Guibert F, Delattre JY, et al. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri. Neurology. 2003; 60: 151

33) Schiff D. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri. Neurology. 2003; 61: 425

34) Perkins GH, Schomer DF, Fuller GN, et al. Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 56: 1137-46

35) Elshaikh MA, Stevens GH, Peereboom DM, et al. Gliomatosis cerebri: treatment results with radiotherapy alone. Cancer. 2002; 95: 2027-31

36) Piccirilli M, Landi A, Salvati M. Gliomatosis cerebri treatment in 11 elderly patients. J Exp Clin Cancer Res. 2006; 25: 183-7

37) Mawrin C. Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease？ Acta Neuropathol (Berl). 2005; 110: 527-36

38) Kros JM, Zheng P, Dinjens WN, et al. Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol. 2002; 61: 806-14

39) Herrlinger U, Felsberg J, Kuker W, et al. Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol. 2002; 52: 390-9

40) Kirches E, Mawrin C, Schneider-Stock R, et al. Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri. J Neurooncol. 2003; 61: 1-5

41) Mawrin C, Lins H, Kirches E, et al. Distribution of p53 alterations in a case of gliomatosis cerebri. Hum Pathol. 2003; 34: 102-6

42) Mawrin C, Kirches E, Schneider-Stock R, et al. Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol (Berl). 2003; 105: 529-36

43) Braeuninger S, Schneider-Stock R, Kirches E, et al. Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri. J Neurooncol. 2007; 82: 23-7

44) Ware ML, Hirose Y, Scheithauer BW, et al. Genetic aberrations in gliomatosis cerebri. Neurosurgery. 2007; 60: 150-8

45) Mawrin C, Kirches E, Schneider-Stock R, et al. Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol. 2005; 72: 115-22

46) Di Ieva A, Gaetani P, Giannini M, et al. Oligodendroglial gliomatosis cerebri. Case report. J Neurosurg Sci. 2006; 50: 123-5

47) Fukushima Y, Nakagawa H, Tamura M. Combined surgery, radiation, and chemotherapy for oligodendroglial gliomatosis cerebri. Br J Neurosurg. 2004; 18: 306-10

48) Tancredi A, Mangiola A, Guiducci A, et al. Oligodendrocytic gliomatosis cerebri. Acta Neurochir (Wien). 2000; 142: 469-72

49) 黒木一彦, 杉山一彦, 田口治義, 他. Gliomatosis cerebriの2症例. 脳神経外科. 2006; 34: 513-8

50) Peretti-Viton P, Brunel H, Chinot O, et al. Histological and MR correlations in Gliomatosis cerebri. J Neurooncol. 2002; 59: 249-59

51) Cummings TJ, Hulette CM, Longee DC, et al. Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis. Clin Neuropathol. 1999; 18: 190-7

52) Kim DG, Yang HJ, Park IA, et al. Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir (Wien). 1998; 140: 755-62

53) Suzuki T, Izumoto S, Fujimoto Y, et al. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion. J Clin Pathol. 2005; 58: 166-71

54) Bernsen H, Van der Laak J, Kusters B, et al. Gliomatosis cerebri: quantitative proof of vessel recruitment by cooptation instead of angiogenesis. J Neurosurg. 2005; 103: 702-6

55) Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2004; 70: 217-28

56) Kunishio K, Okada M, Matsumoto Y, et al. Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol. 2003; 20: 39- 45

57) Mawrin C, Schneider T, Firsching R, et al. Assessment of tumor cell invasion factors in gliomatosis cerebri. J Neurooncol. 2005; 73: 109-15

58) Galatioto S, Marafioti T, Cavallari V, et al. Gliomatosis cerebri. Clinical, neuropathological, immunohistochemical and morphometric studies. Zentralbl. Pathol. 1993; 139: 261-7

59) Wilson NW, Symon L, Lantos PL. Gliomatosis cerebri: report of a case presenting as a focal cerebral mass. J Neurol. 1987; 234: 445-7

60) Hilbig A, Barbosa-Coutinho LM, Toscani N, et al. Expression of nestin and vimentin in gliomatosis cerebri. Arq Neuropsiquiatr. 2006; 64: 781-6

61) Mangiola A, De Bonis P, Guerriero M, et al. Gliomatosis cerebri and pituitary adenoma: case report and literature review. J Neurooncol. 2005; 74: 321-4

62) Riel-Romero RM, Baumann RJ, Smith CD. An unusual complication of cancer treatment for acute lymphoblastic leukemia. J Neurooncol. 2005; 73: 269-72

63) 増岡 淳, 田渕和雄. 大脳膠腫症. 日本臨牀. 2005; 63(Suppl. 9): 128-32

64) Jennings MT, Frenchman M, Shehab T, et al. Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol. 1995; 10: 37-45

65) Taillibert S, Chodkiewicz C, Laigle-Donadey F, et al. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature. J Neurooncol. 2006; 76: 201-5

66) Filley CM, Kleinschmidt-DeMasters BK, Lillehei KO, et al. Gliomatosis cerebri: neurobehavioral and neuropathological observations. Cogn Behav Neurol. 2003; 16: 149-59

67) Caroli E, Orlando ER, Ferrante L. Gliomatosis cerebri in children. Case report and clinical considerations. Childs Nerv Syst. 2005; 21: 1000-3

68) Slee M, Pretorius P, Ansorge O, et al. Parkinsonism and dementia due to gliomatosis cerebri mimicking sporadic Creutzfeldt-Jakob disease (CJD). J Neurol Neurosurg Psychiatry. 2006; 77: 283-4

69) Molho ES. Gliomatosis cerebri may present as an atypical parkinsonian syndrome. Mov Disord. 2004; 19: 341-4

70) 新井政幸, 柏原謙悟, 海崎泰治, 他. 大脳膠腫症─3例の症例報告と最近の文献による考察─. 脳と神経. 2003; 55: 890-7

71) Senatus PB, McClelland S 3rd, Tanji K, et al. The transformation of pediatric gliomatosis cerebri to cerebellar glioblastoma multiforme presenting as supra- and infratentorial acute disseminated encephalomyelitis. Case report. J Neurosurg. 2005; 102(1 Suppl): 72-7

72) Belsare G, Lee AG, Maley J, et al. Pseudo-subarachnoid hemorrhage and cortical visual impairment as the presenting sign of gliomatosis cerebri. Semin Ophthalmol. 2004; 19: 78-80

73) Izumiyama H, Abe T, Tanioka D, et al. Gliomatosis cerebri in a young patient showing various cranial nerve manifestations: a case report. Brain Tumor Pathol. 2003; 20: 93-6

74) Shahar E, Kramer U, Nass D, et al. Epilepsia partialis continua associated with widespread gliomatosis cerebri. Pediatr Neurol. 2002; 27: 392-6

75) Weinberg JS, Rhines LD, Cohen ZR, et al. Posterior fossa decompression for life-threatening tonsillar herniation in patients with gliomatosis cerebri: report of three cases. Neurosurgery. 2003; 52: 216-23

76) Armstrong GT, Phillips PC, Rorke-Adams LB, et al. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia. Cancer. 2006; 107: 1597-606

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp